Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 441-570-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29th April to 12th September 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study conducted in a GLP compliant laboratory according to recognised regulatory Guidelines
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- S-900
- IUPAC Name:
- S-900
- Test material form:
- liquid: viscous
- Details on test material:
- - Name of test material (as cited in study report): s-900
- Physical state: dark brown viscous liquid
- Analytical purity: 98.7%
- Lot/batch No.: 006Y2
- Expiration date of the lot/batch: 6th September 2014
- Storage condition of test material: RT in the dark
- Other:
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: reputable commercial supplier
- Age at study initiation: ca 10 wks males and females
- Weight at study initiation: (P) Males: 333-386 g; Females: 228-265 g;
- Fasting period before study:
- Housing: Cages comprised of a polycarbonate body (and floor) with a stainless steel mesh lid; changed at appropriate intervals. Grid bottomed cages were used during pairing. These were suspended above absorbent paper which was changed daily during pairing.
- Use of restrainers for preventing ingestion (if dermal): yes/no
- Diet (e.g. ad libitum): SDS VRF1 Certified pelleted diet. Non-restricted access
- Water (e.g. ad libitum): ad libitum public supply
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23C
- Humidity (%): 40-70%
- Air changes (per hr): Filtered fresh air which was passed to atmosphere and not recirculated.
- Photoperiod (hrs dark / hrs light): 12h light: 12h Dark
IN-LIFE DATES: From: To: 12th June to 22nd July (Males) or 30th July-5th August (Fermales and litters)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
VEHICLE
- Justification for use and choice of vehicle (if other than water):The homogeneity and stability of the test material in arachis oil was assessed and confirmed at concentrations of 10 mg/mL and 250 mg/mL.
- Concentration in vehicle: 0, 25, 75, 250 mg/mL
- Amount of vehicle (if gavage):4 mL/kg body weight
- Lot/batch no. (if required): N/a
- Purity: Not measured - Details on mating procedure:
- - M/F ratio per cage: 1:1 from within the same treatment groups
- Length of cohabitation: Up to two weeks.
- Proof of pregnancy: Ejected copulation plugs in cage tray and sperm in the vaginal smear referred to as day 0 of pregnancy
- After ... days of unsuccessful pairing replacement of first male by another male with proven fertility.
- Further matings after two unsuccessful attempts: Not required
- After successful mating each pregnant female was caged (how): one female per cage
- Any other deviations from standard protocol: None - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples of each formulation prepared for administration in Week 1 and the last week of treatment were analysed for achieved concentration of the test substance.
- Duration of treatment / exposure:
- Males - for a minimum of four consecutive weeks, including two weeks prior to pairing.
Females - two weeks prior to pairing, throughout mating and gestation and until Day 6 of lactation. - Frequency of treatment:
- Once daily at approximately the same time each day. Animals were not dosed if parturition was in progress at the scheduled time of administration.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: A viability check was performed near the start and end of each working day.
- Cage side observations checked in table [No.?] were included.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Animals were inspected visually at least twice daily for evidence of ill-health or reaction to treatment. Cages and cage-trays were inspected daily for evidence of ill-health amongst the occupant(s). Detailed physical examinations were performed on each animal according to the following
schedule: Males - weekly throughout the treatment period; Females - weekly until mated, then Days 0, 7, 14 and 20 of gestation and Days 1 and 7 of lactation
BODY WEIGHT: Yes
- Time schedule for examinations:
F0 Males Day that treatment commenced (Week 0), Each week, At necropsy
F0 Females Day that treatment commenced (Week 0), Each week until mating was detected, Days 0, 3, 7, 10, 14, 17 and 20 after mating, Days 1, 4 and 7 of lactation
OTHER: Food consumption
The weight of food supplied to each cage, that remaining and an estimate of any spilled was recorded was recorded as follows:
F0 males Weekly before pairing. From these records the mean weekly consumption per animal (g/rat/week) was calculated for each cage.
F0 females Weekly until paired for mating. From these records the mean weekly consumption per animal (g/rat/week) was calculated for each cage
Following pairing, on Days 0-2, 3-6, 7-9, 10-13, 14-16 and 17-19 after mating and Days 1-3 and 4-6, of lactation. From these records the mean daily consumption (g/rat/day) was calculated for each animal - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: no
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, litter mean body weight (+ SD) was calculated separately for males and females, organs weights at necropsy
GROSS EXAMINATION OF DEAD PUPS:
yes for external and internal abnormalities; possible cause of death was/was not determined for pups born or found dead.] - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals during week 5 of respective treatment
- Maternal animals: All surviving animals day 7 of lactation or day 25 after last day of pairing for F0 females failing to produce a viable litter
GROSS NECROPSY
- All F0 adult animals were subject to a detailed necropsy. After a review of the history of each animal, a full macroscopic examination of the tissues was performed. All external features and orifices were examined visually.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated below were prepared for microscopic examination and weighed, respectively:
Abnormalities, Epididymides (caput, corpus and cauda), Ovaries, Pituitary, Prostate , Seminal vesicles (with coagulation gland), Testes, Uterus with cervix and oviducts, Vagina - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring were sacrificed at 7 days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY
- Gross necropsy consisted of external examinations
HISTOPATHOLOGY / ORGAN WEIGTHS
Tissues from the F1 offspring were not prepared for microscopic examination. - Statistics:
- Statistical analyses were performed on the majority of data presented and results of these tests, whether significant or non-significant, are presented on the relevant tables. For some parameters, including pre-coital interval, and mating performance and fertility the similarity of the data was such that analyses were not considered to be necessary:
All statistical analyses were carried out separately for males and females. For all other adult parameters, the analyses were carried out using the individual animal as the basic experimental unit. For litter findings the litter was taken as the treated unit and the basis for statistical analysis and biological significance was assessed with relevance to the severity of the anomaly and the incidence of the finding within the background control population.
A parametric analysis was performed if Bartlett's test for variance homogeneity was not significant at the 1% level. For pre-treatment data, analysis of variance was used to test for any group differences. Where this was significant (p<0.05) inter group comparisons using t-tests, with the error mean square from the one-way analysis of variance, were made. For all other analyses the F1 approximate test was applied.
A non-parametric analysis was performed if Bartlett's test was still significant at the 1% level following both logarithmic and square-root transformations. For pre-treatment data, Kruskal-Wallis’ test (Kruskal and Wallis 1952, 1953) was used to test for any group differences. Where this was significant (p<0.05) inter group comparisons using Wilcoxon rank sum tests (Wilcoxon 1945) were made. For all other analyses t/The H1 approximate test, the non-parametric equivalent of the F1 test described above, was applied.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- When compared with Control, overall body weight gain in females receiving 300 or 1000 mg/kg/day, during the two week pre-mating period was low (X 0.77 or 0.67, respectively).
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
Effect levels (P0)
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Clinical signs recorded for the offspring identified occasional pups with findings, but the type of findings and incidence were typical and showed no relationship to parental treatment.
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- The predominant macropathology finding among the small number of decedent offspring on the study was no milk in stomach. This is a common finding and, in the absence of an effect upon offspring survival, is considered to be of no toxicological significanc
- Histopathological findings:
- not specified
Details on results (F1)
the study was no milk in stomach. This is a common finding and, in the absence of an effect
upon offspring survival, is considered to be of no toxicological significance.
Effect levels (F1)
- Key result
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- For general toxicity, the no-observed-effect level (NOEL) was considered to be 1000 mg/kg/day and for reproductive /developmental toxicity the NOEL was 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)